Goal-directed therapy in osteoporosis

被引：11

作者：

McCloskey, Eugene ^{[1
,2
]}

Leslie, William D. ^{[3
]}

机构：

[1] No Gen Hosp, WHO Collaborating Ctr Metab Bone Dis, Metab Bone Ctr, Sheffield S5 7AU, S Yorkshire, England

[2] No Gen Hosp, Acad Unit Bone Metab, Metab Bone Ctr, Sheffield S5 7AU, S Yorkshire, England

[3] Univ Manitoba, Dept Med, Winnipeg, MB, Canada

来源：

JOURNAL OF BONE AND MINERAL RESEARCH | 2013年 / 28卷 / 03期

关键词：

BONE-MINERAL DENSITY; GLUCOCORTICOID-INDUCED OSTEOPOROSIS; NONVERTEBRAL FRACTURE RISK; REDUCTION; GUIDELINES; MANAGEMENT; TURNOVER; TRIAL; WOMEN; DIAGNOSIS;

D O I：

10.1002/jbmr.1859

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：439 / 441

页数：3

共 24 条

[1]

Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures [J].

Austin, Matthew ;

Yang, Yu-Ching ;

Vittinghoff, Eric ;

Adami, Silvano ;

Boonen, Steven ;

Bauer, Douglas C. ;

Bianchi, Gerolamo ;

Bolognese, Michael A. ;

Christiansen, Claus ;

Eastell, Richard ;

Grauer, Andreas ;

Hawkins, Federico ;

Kendler, David L. ;

Oliveri, Beatriz ;

McClung, Michael R. ;

Reid, Ian R. ;

Siris, Ethel S. ;

Zanchetta, Jose ;

Zerbini, Cristiano A. F. ;

Libanati, Cesar ;

Cummings, Steven R. .

JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (03) :687-693

[2]

National Bone Health Alliance Bone Turnover Marker Project: current practices and the need for US harmonization, standardization, and common reference ranges [J].

Bauer, D. ;

Krege, J. ;

Lane, N. ;

Leary, E. ;

Libanati, C. ;

Miller, P. ;

Myers, G. ;

Silverman, S. ;

Vesper, H. W. ;

Lee, D. ;

Payette, M. ;

Randall, S. .

OSTEOPOROSIS INTERNATIONAL, 2012, 23 (10) :2425-2433

[3]

Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data [J].

Bell, Katy J. L. ;

Hayen, Andrew ;

Macaskill, Petra ;

Irwig, Les ;

Craig, Jonathan C. ;

Ensrud, Kristine ;

Bauer, Douglas C. .

BMJ-BRITISH MEDICAL JOURNAL, 2009, 338 :1553

[4]

Risk of fracture among women who lose bone density during treatment with alendronate. The Fracture Intervention Trial [J].

Chapurlat, RD ;

Palermo, L ;

Ramsay, P ;

Cummings, SR .

OSTEOPOROSIS INTERNATIONAL, 2005, 16 (07) :842-848

[5]

Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK [J].

Compston, J. ;

Cooper, A. ;

Cooper, C. ;

Francis, R. ;

Kanis, J. A. ;

Marsh, D. ;

McCloskey, E. V. ;

Reid, D. M. ;

Selby, P. ;

Wilkins, M. .

MATURITAS, 2009, 62 (02) :105-108

[6]

Monitoring bone mineral density during antiresorptive treatment for osteoporosis [J].

Compston, Juliet .

BMJ-BRITISH MEDICAL JOURNAL, 2009, 338

[7]

Monitoring osteoporosis therapy with bone densitometry - Misleading changes and regression to the man [J].

Cummings, SR ;

Palermo, L ;

Browner, W ;

Marcus, R ;

Wallace, R ;

Pearson, J ;

Blackwell, T ;

Eckert, S ;

Black, D .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (10) :1318-1321

[8]

Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs [J].

Cummings, SR ;

Karpf, DB ;

Harris, F ;

Genant, HK ;

Ensrud, K ;

LaCroix, AZ ;

Black, DM .

AMERICAN JOURNAL OF MEDICINE, 2002, 112 (04) :281-289

[9]

Goal-directed treatment of osteoporosis [J].

Cummings, Steven R. ;

Cosman, Felicia ;

Eastell, Richard ;

Reid, Ian R. ;

Mehta, Mona ;

Lewiecki, E. Michael .

JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28 (03) :433-438

[10]

The potential impact of the National Osteoporosis Foundation guidance on treatment eligibility in the USA: an update in NHANES 2005-2008 [J].

Dawson-Hughes, B. ;

Looker, A. C. ;

Tosteson, A. N. A. ;

Johansson, H. ;

Kanis, J. A. ;

Melton, L. J., III .

OSTEOPOROSIS INTERNATIONAL, 2012, 23 (03) :811-820

← 1 2 3 →